Efficacy of continuous plasma diafiltration therapy in critical patients with acute liver failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 4, 2014, Pages 782-786

  Komura, Takuya ^a,b   Taniguchi, Takumi ^a   Sakai, Yoshio ^b   Yamashita, Tatsuya ^b   Mizukoshi, Eishiro ^b   Noda, Toru ^a   Okajima, Masaki ^a,b   Kaneko, Shuichi ^b  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acute kidney disease; Acute liver failure; Blood purification therapy; Plasma exchange

Indexed keywords

BILIRUBIN;

ACUTE LIVER FAILURE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CRITICALLY ILL PATIENT; END STAGE LIVER DISEASE; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FUNCTION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; SAFETY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL RATE; THERAPY EFFECT;

ACUTE KIDNEY DISEASE; ACUTE LIVER FAILURE; BLOOD PURIFICATION THERAPY; PLASMA EXCHANGE;

ADULT; BILIRUBIN; BIOLOGICAL MARKERS; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HEMODIAFILTRATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROTHROMBIN TIME; SAFETY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84896335872     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12440     Document Type: Article

References (20)

1. Bernuau J, Benhamou JP. Classifying acute liver failure. Lancet 1993; 342: 252-253.
2. Tandon BN, Bernauau J, O'Grady J etal. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J. Gastroenterol. Hepatol. 1999; 14: 403-404.
3. Lee WM. Acute liver failure. N. Engl. J. Med. 1993; 329: 1862-1872.
4. Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol. Res. 2008; 38: 646-657.
5. Ikegami T, Taketomi A, Soejima Y etal. Living donor liver transplantation for acute liver failure: a 10-year experience in a single center. J. Am. Coll. Surg. 2008; 206: 412-418.
6. Matsui Y, Sugawara Y, Yamashiki N etal. Living donor liver transplantation for fulminant hepatic failure. Hepatol. Res. 2008; 38: 987-996.
7. Mohamed El Moghazy W, Ogura Y, Mutsuko M, Harada K, Koizumi A, Uemoto S. Pediatric living-donor liver transplantation for acute liver failure: analysis of 57 cases. Transpl. Int. 2010; 23: 823-830.
8. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179-1197.
9. Saibara T, Maeda T, Onishi S, Yamamoto Y. Plasma exchange and the arterial blood ketone body ratio in patients with acute hepatic failure. J. Hepatol. 1994; 20: 617-622.
10. Nakamura T, Ushiyama C, Suzuki S etal. Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purif. 2000; 18: 50-54.
11. Mori T, Eguchi Y, Shimizu T etal. A case of acute hepatic insufficiency treated with novel plasmapheresis plasma diafiltration for bridge use until liver transplantation. Ther. Apher. 2002; 6: 463-466.
12. Rozga J, Umehara Y, Trofimenko A, Sadahiro T, Demetriou AA. A novel plasma filtration therapy for hepatic failure: preclinical studies. Ther. Apher. 2006; 10: 138-144.
13. Nakae H, Eguchi Y, Saotome T etal. Multicenter study of plasma diafiltration in patients with acute liver failure. Ther. Apher. 2010; 14: 444-450.
14. Mochida S, Takikawa Y, Nakayama N etal. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol. Res. 2011; 41: 805-812.
15. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754-1758.
16. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry. Liver 2002; 22 (Suppl. 2): 20-25.
17. Rifai K, Ernst T, Kretschmer U etal. Prometheus-a new extracorporeal system for the treatment of liver failure. J. Hepatol. 2003; 39: 984-990.
18. John S, Griesbach D, Baumgärtel M, Weihprecht H, Schmieder RE, Geiger H. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol. Dial. Transplant. 2001; 16: 320-327.
19. Hirasawa H, Sugai T, Oda S etal. Efficacy and limitation of apheresis therapy in critical care. Ther. Apher. 1997; 1: 228-232.
20. Mehta RL, Kellum JA, Shah SV etal. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 2007; 11: R31.